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Abstract 
BACKGROUND The aim was to investigate the comorbidity profile of people with dementia 
and examine the associations between severity of comorbidity, health-related quality of life 
(HRQoL) and quality of life (QoL). 
METHODS The Improving the experience of Dementia and Enhancing Active Life (IDEAL) 
cohort consisted of 1,547 people diagnosed with dementia who provided information on the 
number and type of comorbid conditions. Participants also provided ratings of their health 
related and dementia-specific quality of life.  
RESULTS The majority of the sample were living with more than one chronic condition. 
Hypertension was commonly reported and frequently combined with connective tissue 
disease, diabetes, and depression. The number of comorbid conditions was associated with 
low quality of life scores, and those with severe comorbidity (>5 conditions) showed the 
greatest impact on their well-being.  
CONCLUSIONS Comorbidity is an important risk factor for poor quality of life and health 
status in people with dementia. Greater recognition of the nature and impact of comorbidity is 
needed to inform support and interventions for people with dementia and a multidisciplinary 
approach to care provision is recommended.  
 
Key Points 
•   The majority of people with dementia were living with one or two chronic health 
conditions, and hypertension was the most frequent comorbid condition. 
•   Multiple health conditions have important consequences for the quality of life (QoL) 
and well-being of the individual. 
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•   This study highlights the need for better care planning and the organization of care 
provision to deal with multiple conditions in an integrated way. 
 
Keywords: Alzheimer’s, Multimorbidities, Depression   
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Living with dementia poses many challenges for people with dementia and for those who 
care for them. This may be coupled with other health problems as the accumulation of 
changes associated with ageing can lead to the accrual of illnesses and disabilities [1]. With 
the increased prevalence of individual health conditions associated with ageing [2] there is 
growing interest in the co-occurrence of medical conditions and the implications for the 
individual. Multimorbidity and comorbidity are used interchangeably to describe the presence 
of co-occurring diseases but definitions vary across studies. Multimorbidity is the co-
occurrence of two or more diseases or active health conditions that may or may not be linked 
by a causal relationship or with no consistent dominant index disorder. Comorbidity is the 
term given to the presence of conditions existing concurrently with a condition considered as 
the primary or index disease [1] and this study will focus on the presence of conditions in 
addition to dementia as the index condition. Comorbidities significantly associated with 
dementia include physical health conditions such as congestive cerebrovascular disease, and 
cardiac arrhythmia [3], hypertension and diabetes [4], and depression [5]. 
 
People with dementia are more likely to have 5 or more health conditions and more 
prescription usage than those without dementia [6], and comorbidity ranging from 2-8 
conditions has been reported [7]. Examination of the medical records in England showed that 
92% of people with dementia had a formal diagnosis of at least one other disease, and 53% 
were considered to have comorbidity with 3 or more conditions [2]. Similarly, 61% of people 
with Alzheimer’s disease across various care settings had 3 or more conditions [8]. Co-
morbidity rates were the same for people with dementia compared with those without 
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dementia in a primary care [7], but for care home residents, rates were higher in people with 
dementia compared with older care residents without dementia [9]. There is growing interest 
not only in the number of comorbid conditions but also in the combinations or array of 
conditions referred to as ‘morbidotypes’ [10].  
 
Comorbidity can influence a range of health outcomes such as mortality [11] and disability 
[12]. Multimorbidity is negatively associated with health related quality of life (HRQoL) [9, 
13], and certain disease combinations, such as diabetes and coronary disorders, impact more 
on HRQoL than others [14]. Higher comorbidity in people with dementia is negatively 
associated with ratings of disease specific QoL [15]. Generally there is a negative association 
between comorbidity and QoL but the results are not conclusive, with variable findings 
related to QoL and HRQoL [16], and few studies examining both perceptions of health 
related quality of life and well-being. 
 
People with dementia are living with comorbidity, and greater recognition of the extent and 
impact of this burden of disease is essential for the identification of interventions to help 
maintain independence and improve QOL [17]. Comorbidity poses significant challenges for 
care provision, and greater coordination of care planning across conditions is needed [4, 18]. 
The aim of this study is to investigate the comorbidity profile of people with dementia and to 
examine the associations between severity of comorbidity, HRQoL and QoL using a large 
community-based cohort of people with dementia.  
 
 
Method 
Sample 
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Participants were drawn from the baseline wave of the ‘Improving the experience of 
Dementia and Enhancing Active Life’ (IDEAL) longitudinal cohort study recruited across 
Great Britain [19]. Inclusion criteria included a clinical diagnosis of dementia and a Mini-
Mental State Examination (MMSE) score ≥15 [20]. Interviews were conducted in participant 
homes. Analysis is based on V2 of the IDEAL baseline (T1) dataset. 
 
Ethics Statement 
Written informed consent was secured for all participants. Ethics approval was granted by the 
Wales Research Ethics Committee 5 (reference 13/WA/0405) and the Ethics Committee of 
the School of Psychology, Bangor University (reference 2014-11684). The IDEAL study is 
registered with UKCRN, registration number 16593. 
 
Measures 
Information on the age profile, diagnostic subtypes and educational level of the cohort was 
included in analyses.  
 
Comorbidity  
A record of the presence or absence of 23 chronic conditions was collected using the 
Charlson Comorbidity Index (CCI) [21], administered through a joint interview with the 
person with dementia and carer where available. The CCI included diseases selected on the 
basis of their association with mortality and this version of the CCI includes depression, 
hypertension, ulcers, and use of warfarin [21]. A count of the diseases within the index is 
used as a measure of comorbidity, and as we were interested in the impact of diseases in 
addition to our index condition dementia was not counted in the analysis. Comorbidity was 
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categorized into four levels of severity: no comorbidity; mild (1–2 conditions); moderate (3–4 
conditions); and severe (≥5 conditions).  
 
Health-Related Quality of Life (HRQoL) 
Participants rated their HRQoL using the two parts of the EQ-5D-3L [22]:  
1.   The EQ-5D-3L descriptive system has five dimensions: mobility, self-care, usual 
activities, pain/discomfort, and anxiety/depression. The EQ-5D dimensions were 
dichotomised into ‘no problems’ and ‘moderate/severe problems’ for logistic 
regression analyses. 
2.   The EQ-5D visual analogue scale (EQ-5D VAS) provides a self-rating of health on a 
vertical visual analogue scale from 0 = ‘worst imaginable health state’ to 100 = ‘best 
imaginable health state’. This is used as a quantitative measure of HRQoL.  
 
Quality of Life 
The Quality of Life in Alzheimer’s Disease (QoL-AD) scale was developed specifically for 
people with dementia and focuses on QoL domains important in cognitively impaired older 
people. Participants rate aspects of their current situation such as mood, memory, and make a 
global assessment of QoL as a whole [23]. Scale scores range from 13-52, with higher scores 
representing greater QoL.  
 
Statistical analyses 
The analysis first investigated the frequencies and prevalence of different conditions and their 
combinations. Linear regression was conducted to investigate the associations between 
severity of comorbidity and both HRQoL and QoL-AD. The associations between severity of 
comorbidity and the five individual dimensions of the EQ-5D were examined using logistic 
Running head:  Comorbidity and Quality of Life in Dementia  
regression. The models were adjusted for participants’ socio-demographic characteristics 
including age, gender, education and dementia subtype.  
 
Results 
The IDEAL cohort consisted of 1,547 people diagnosed with dementia at baseline; 56.3% 
were male. The mean MMSE score was 24.15 (s.d. 3.46; range 14-30). The mean age of the 
people with dementia was 76.4 (s.d. 8.5). The majority of the sample had a diagnosis of 
Alzheimer’s disease (55.5%). Characteristics of the sample are presented in Table 1. 
 
The average HRQoL score was 71.93 (s.d. 18.61), with an average QoL-AD score of 36.77 
(s.d. 5.92). Information on the EQ-5D domains is shown in Table 1, with moderate or severe 
difficulties reported with mobility (41.8%), self-care (17.2%), performance of usual activities 
(34%), pain (40.2%) and anxiety or depression (34%).  
 
Insert Table 1 here  
 
Prevalence and Combinations of Comorbid Conditions  
The median number of comorbid conditions reported was 1, with a range from 0-9. The 
prevalence of the individual comorbid conditions included in the CCI for the whole sample 
and by gender is shown in Figure 1. The five most frequent conditions across the cohort 
were: hypertension (38.7%); connective tissue disease (24.5%); depression (15.4%); diabetes 
(12.7%) and chronic pulmonary disease (12.5%). This pattern of prevalence was similar in 
both males and females with the exception of the higher prevalence of myocardial infarction 
in men (11.6%) vs. 5.3% in women.  
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Over 300 combinations of comorbid conditions were found but most combinations had low 
frequencies (N<10). The most frequent two-way comorbidities were hypertension with 
connective tissue disease (N=43), hypertension and diabetes (N=24), and hypertension and 
depression (N=22). Three-way comorbid combinations follow a similar pattern with 
hypertension present in all three of the top combinations: hypertension, connective disease 
and diabetes (N=12); hypertension, cardiovascular disease and connective tissue disease 
(N=8); and myocardial infarction, hypertension and connective tissue disease (N=7). 
Insert Figure 1 here  
 
Table 1 reports the number of comorbid conditions by sociodemographic factors. Twenty five 
percent of the sample did not report the presence of any comorbid condition. The majority 
(52%) had mild (1-2 conditions) comorbidity and only 5% had severe comorbidity (>5 
conditions). The distribution was similar across gender and age groups but varied across 
dementia subtypes. The percentage of vascular dementia and mixed AD and VD subtypes 
increased with the severity of comorbid conditions. 
 
Table 2 reports the associations between level of comorbidity and ratings on the QoL-AD and 
the EQ-5D. There was a negative association between severity of comorbid conditions and 
both QoL-AD and HRQoL scores. Compared to those with no chronic conditions, 
participants with severe comorbidity (≥5 conditions) had lower QoL-AD by 6 points (-5.84; 
95% CI: -7.27, -4.41) and lower HRQoL scores by 18 points (-17.82; 95% CI: -22.23,  
-13.42). After adjusting for age, sex, dementia subtypes and education, the adjusted estimates 
were -5.07 (95% CI: -6.53, -3.62) for QoL-AD and -15.85 (95% CI: -20.36, -11.34) for 
HRQoL. 
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For the five EQ5D domains severe comorbidity was also associated with higher odds of 
moderate/severe problems in mobility (OR=14.64; 95% CI:7.54, 28.41), self-care issues 
(OR=6.46; 95% CI: 3.44, 12.13), impairment in usual activities (OR=5.77; 95% CI: 3.28, 
10.15), pain/discomfort (OR=8.51; 95% CI: 4.72, 15.36) and anxiety/depression (OR=2.81; 
95% CI: 1.66, 4.74) after adjustment for socio-demographic factors (see Table 2).  
 
 
 
Discussion 
 
 
Using dementia as the index disease, this study examined the co-occurrence and 
combinations of conditions in people with dementia living in the community. The majority 
were living with one or two chronic health conditions, with 5% reporting more than 5 
comorbidities. Hypertension was the most frequent comorbid condition. The severity of 
comorbid conditions was associated with lower both HRQoL and dementia-specific QoL. 
People with severe comorbid conditions had higher odds of problems in mobility, self-care, 
managing usual activities, pain and mood. The IDEAL cohort had similar rates of 
comorbidity as those previously reported for people living with dementia [6], with 74% of 
people reporting more than one condition. Prevalence rates for comorbidity vary across living 
situation and stages of dementia [7]. Comorbidities linked with dementia identified through 
medical records report than 92% live with more than one condition [2]. Differences in 
prevalence rates may be attributed to the broader range of conditions encompassed in reviews 
of medical records than those collected by self-report [3].  
 
Comorbidities most prevalent in the dementia cohort were hypertension, connective tissue 
disease, depression, diabetes, and chronic pulmonary disease. Combinations of conditions 
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included hypertension with connective tissue disease, diabetes, and depression. Hypertension 
prevalence rates are high in this age group [24]. For the main comorbidities we identified 
there are known associations between both Alzheimer’s disease and vascular dementia and 
hypertension [25], and diabetes is a risk factor for Alzheimer’s disease and dementia [26]. 
Depression in mid- to late life has been linked with an increased risk of dementia [27], and 
the prevalence of depression in people with Alzheimer’s disease is high [28].  
 
People with multiple chronic conditions were at greater risk of health problems in mobility, 
self-care, usual activities, pain/discomfort and anxiety/depression compared with people 
living with dementia only. The severity of comorbid conditions was negatively associated 
with global ratings of HRQoL, consistent with previous studies [9, 13], and with disease-
specific assessment of QoL [15]. Previous research has considered the impact of comorbidity 
in one QoL domain [9] and this study provides additional evidence that comorbidity may 
have a substantial impact on a person’s subjective perception of ill health and perceptions of 
well-being related to dementia.  
 
There are some limitations in the measurement of comorbidity within the study. Reliance on 
patient-reported comorbidity may have led to the under-reporting of comorbid conditions and 
confirmation with medical records is recommended for future studies [29]. The CCI mainly 
considers physical health conditions, and depression is the only mental health condition 
included. Depression can have an independent negative impact on QOL as well as amplifying 
the impact of physical conditions on perceived QOL [5]. The CCI does not encompass other 
physical changes or challenges associated with ageing (e.g. falls or frailty) that may also 
impact on QoL. There is growing recognition of the importance of considering frailty in 
combination with comorbidity [30], and this has also extended to clinical guidelines [18]. A 
Running head:  Comorbidity and Quality of Life in Dementia  
longitudinal perspective on the impact of comorbidity as dementia progresses would be 
useful, as the comorbidity may differ across stages of dementia and new chronic conditions 
may arise. 
 
Comorbidity in dementia may have serious implications for well-being, and information on 
the nature of comorbidity is needed to plan adequate support and interventions [17]. The 
issue of comorbidity poses significant challenges for care provision [4]. Dementia may 
impact on decision-making and on the self-management of chronic conditions [7]. There has 
been a move to identify groups at whom interventions to deal with comorbidity should be 
targeted; those at most risk are people who find it difficult to manage everyday activities, 
those who are frail, and those who receive care from multiple sources [18].  
 
This study suggests that comorbidity is an important risk factor for poor health and global 
well-being in people with dementia. It is evident that people with dementia are experiencing 
the impact of living with multiple diseases and there is need for greater support and 
intervention in care provision and planning. Care providers often focus on individual 
conditions and this study highlights the need for better care planning and the organization of 
care provision to deal with multiple conditions in an integrated way. The presence of multiple 
conditions is likely to increase the burden on carers who support people with dementia and 
the implications of this additional responsibility for carers should also be considered.  
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Table 1 Demographic Characteristics of the Sample and Level of Comorbid Conditions 
 
Characteristics N (%) Comorbid Conditions N (%) 
Missing (n=85) 
  0 
None 
1-2  
Mild 
3-4 
Moderate 
>5 
Severe 
N 1547 365 (25) 757 (52) 259 (17) 81 (5) 
Age Groups 
<65  
65-69 
70-74 
75-79 
80+ 
 
136   (8.8) 
178 (11.5) 
260 (16.8) 
370 (23.9) 
603 (38.9) 
 
48 (13.2) 
44 (12.0) 
70 (19.2) 
83 (22.7) 
120 (32.9) 
 
60   (7.9) 
95 (12.5) 
122 (16.2) 
184 (24.3) 
296 (39.1) 
 
14  (5.4) 
23  (8.8) 
39 (15.0) 
62 (23.9) 
122 (46.7) 
 
10 (12.3) 
10 (12.3) 
13 (16.1) 
21 (25.9) 
27 (33.3) 
Sex  
Male  
Female 
 
872 (56.3) 
675 (43.6) 
 
198 (54.2) 
167 (45.7) 
 
430 (56.8) 
327 (43.2) 
 
143 (55.2) 
116 (44.7) 
 
54 (66.6) 
27 (33.3) 
Dementia Diagnosis 
Alzheimer’s disease 
Vascular dementia 
Mixed (Alzheimer’s & Vascular) 
Frontotemporal dementia 
Parkinson’s disease dementia 
Lewy body dementia 
Unspecified /Other  
 
858 (55.5) 
171 (11.0) 
326 (21.0) 
54 (3.5) 
44 (2.8) 
53 (3.4) 
41 (2.7) 
 
246 (67.4) 
21 (5.7) 
45 (12.2) 
20 (5.5) 
 8 (2.2) 
15 (4.1) 
10 (2.7) 
 
435 (57.5) 
64 (8.5) 
161 (21.3) 
26 (3.4) 
25 (3.3) 
26 (3.4) 
20 (2.6) 
 
108 (41.7) 
56 (21.6) 
73 (28.2) 
6 (2.3) 
4 (1.5) 
7 (2.7) 
2 (2.5) 
 
34 (41.9) 
18 (22.2) 
25 (30.8) 
0 (0.0) 
2 (2.5) 
2 (2.7) 
0 (0.0) 
QoL-AD Total Score Mean (SD) 36.7 (5.9) 38.6 (5.7) 37.1 (5.6) 34.5 (5.8) 32.7 (5.4) 
EQ-5D VAS Mean (SD) 71.9 (18.6) 77.7 (16.7) 72.5 (17.8) 66.5 (19.3) 59.9 (21.5) 
EQ-5D Problems N (%)      
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Mobility None  897 (58.1) 280 (77.1) 458 (60.6) 101 (39.0) 14 (17.3) 
 Moderate/Severe 646 (41.8) 83 (22.8) 297 (39.3) 158 (61.0) 67 (82.7) 
Self-Care None  1209 (82.8) 331 (90.9) 643 (84.2) 187 (72.0) 48 (59.2) 
 Moderate/Severe 252 (17.2) 33 (9.1) 114 (15.6) 72 (27.8) 33 (40.7) 
Usual Activities None  1018 (66.1) 277 (76.3) 532 (70.6) 140 (54.2) 27 (33.3) 
 Moderate/Severe 522 (33.9) 86 (23.7) 221 (29.3) 118 (45.7) 54 (66.6) 
Pain/Discomfort None  924 (59.8) 276 (75.8) 456 (60.3) 120 (46.5) 20 (24.7) 
 Moderate/Severe 620 (40.2) 88 (24.2) 300 (39.7) 138 (53.4) 61 (75.3) 
Anxiety/Depression None  1014 (65.8) 260 (71.4) 518 (68.7) 144 (56.0) 38 (46.9) 
 Moderate/Severe 526 (34.2) 104 (28.6) 236 (31.3) 113 (43.9) 43 (53.1) 
 
Note: QoL-AD = Quality of Life in Alzheimer’s Disease, VAS = visual analogue scale 
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Table 2 Unadjusted and adjusted associations between comorbidity, health-rated quality of 
life (EQ-5D) and quality of life (QoL-AD) and the five EQ-5D domains 
 Unadjusted Model Adjusted Model* 
 Coeff. (95% CI) Coeff. (95% CI) 
QoL-AD:   
1-2 Mild vs None -1.45 (-2.19, -0.70) -1.35 (-2.09, -0.62) 
3-4 Moderate vs None -4.16 (-5.13, -3.20) -4.07 (-5.05, -3.09) 
>5 Severe vs None -5.84 (-7.27, -4.41) -5.07 (-6.53, -3.62) 
EQ-5D VAS:   
1-2 Mild vs None   -5.15 (-7.43, -2.87) -4.85 (-7.13, -2.57) 
3-4 Moderate vs None -11.14 (-14.04, -8.24) -10.58 (-13.53, -7.63) 
>5 Severe vs None -17.82 (-22.23, -13.42) -15.85 (-20.36, -11.34) 
EQ-5D domains: OR (95% CI) OR (95% CI) 
EQ-5D Mobility   
1-2 Mild vs None 2.18 (1.64, 2.90) 1.98 (1.46, 2.68) 
3-4 Moderate vs None 5.27 (3.71, 7.48) 4.44 (3.06, 6.45) 
>5 Severe vs None 16.14 (8.63, 30.18) 14.64 (7.54, 28.41) 
EQ-5D Self-care   
1-2 Mild vs None 1.77 (1.18, 2.67) 1.85 (1.20, 2.87) 
3-4 Moderate vs None 3.86 (2.46, 6.05) 4.50 (2.75, 7.37) 
>5 Severe vs None 6.89 (3.90, 12.18) 6.46 (3.44, 12.13) 
EQ-5D Usual activities   
1-2 Mild vs None 1.33 (1.00, 1.78) 1.24 (0.90, 1.69) 
3-4 Moderate vs None 2.71 (1.92, 3.83) 2.44 (1.68, 3.55) 
>5 Severe vs None 6.44 (3.82, 10.85) 5.77 (3.28, 10.15) 
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EQ-5D Pain/discomfort   
1-2 Mild vs None 2.06 (1.55, 2.73) 1.97 (1.47, 2.64) 
3-4 Moderate vs None 3.60 (2.56, 5.08) 3.43 (2.38, 4.92) 
>5 Severe vs None 9.56 (5.46, 16.73) 8.51 (4.72, 15.36) 
EQ-5D Anxiety/Depression   
1-2 Mild vs None 1.13 (0.86, 1.49) 1.18 (0.89, 1.58) 
3-4 Moderate vs None 1.96 (1.40, 2.74) 2.17 (1.52, 3.10) 
>5 Severe vs None 2.83 (1.72, 4.62) 2.81 (1.66, 4.74) 
 Unadjusted Model Adjusted Model* 
 Coeff. (95% CI) Coeff. (95% CI) 
QoL-AD:   
1-2 Mild vs None -1.49 (-2.21, -0.76) -1.35 (-2.06, -0.64) 
3-4 Moderate vs None -4.49 (-5.47, -3.51) -4.38 (-5.37, -3.40) 
>5 Severe vs None -5.86 (-7.34, -4.38) -5.20 (-6.69, -3.72) 
EQ-5D VAS:   
1-2 Mild vs None   -5.28 (-7.49, -3.07) -4.95 (-7.14, -2.75) 
3-4 Moderate vs None -10.39 (-13.32, -7.46) -9.97 (-12.94, -6.99) 
>5 Severe vs None -19.06 (-23.64, -14.50) -17.46 (-22.06, -12.86) 
EQ-5D domains: OR (95% CI) OR (95% CI) 
EQ-5D Mobility   
1-2 Mild vs None 2.04 (1.56, 2.68) 1.87 (1.41, 2.49) 
3-4 Moderate vs None 4.42 (3.13, 6.25) 3.71 (2.57, 5.35) 
>5 Severe vs None 18.79 (9.28, 38.06) 16.91 (8.19, 34.91) 
EQ-5D Self-care   
1-2 Mild vs None 1.88 (1.27, 2.79) 1.94 (1.27, 2.94) 
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3-4 Moderate vs None 3.88 (2.49, 6.06) 4.56 (2.80, 7.42) 
>5 Severe vs None 6.74 (3.77, 12.07) 6.84 (3.63, 12.87) 
EQ-5D Usual activities   
1-2 Mild vs None 1.36 (1.03, 1.80) 1.28 (0.95, 1.73) 
3-4 Moderate vs None 2.92 (2.06, 4.12) 2.74 (1.88, 3.98) 
>5 Severe vs None 6.82 (3.95, 11.79) 6.15 (3.45, 10.97) 
EQ-5D Pain/discomfort   
1-2 Mild vs None 1.89 (1.45, 2.47) 1.80 (1.37, 2.38) 
3-4 Moderate vs None 3.23 (2.30, 4.54) 3.06 (2.14, 4.38) 
>5 Severe vs None 9.96 (5.47, 18.13) 8.99 (4.84, 16.68) 
EQ-5D Anxiety/Depression   
1-2 Mild vs None 1.19 (0.91, 1.55) 1.23 (0.93, 1.62) 
3-4 Moderate vs None 1.99 (1.42, 2.80) 2.26 (1.58, 3.23) 
>5 Severe vs None 3.17 (1.90, 5.30) 3.58 (2.09, 6.14) 
*Adjusted for age group, sex, dementia subtypes and education. 
Note: QoL-AD = Quality of Life in Alzheimer’s Disease, VAS = visual analogue scale 
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Figure 1: Prevalence of Comorbid Conditions Associated with Dementia  
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